Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Cupid Ltd (CUPID) Share Price & Fundamentals

Company Overview

Founded Year

1993

Listed Year

-

Headquarter

Nashik, Maharashtra, India

MD/CEO

Aditya Kumar Halwasiya

Website

https://www.cupidlimited.com

Company Facts

What we do

Cupid Limited manufactures and exports male and female condoms, lubricant jelly, in vitro diagnostic devices, and personal care FMCG products with global certifications.

Founded in

1,993

Market share

Leading global supplier with exports to 125+ countries, trusted by WHO/UNFPA and other global institutions.

Problem solved

Provides essential sexual health protection products and diagnostics addressing global public health and personal care needs.

Top clients or who we serve

Global public health programs, governments, hospitals, retailers; operates B2B exports and B2C FMCG segments.

Key management

Aditya Kumar Halwasiya (Chairman & Managing Director)

Our journey and innovations

Started in 1993 with male condoms; expanded to female condoms, lubricants, diagnostics (2023), and FMCG personal care products (2024).

Where we operate

Exports worldwide (125+ countries), domestic India market, expanding in GCC region.

Top products or what we offer

Male/Female condoms, lubricant jelly, in vitro diagnostic kits, deodorants, perfumes, face wash, and personal care items.

Top brands

Cupid condoms, Cupid Angel female condom, CupiSURE IVD kits, Cupid personal care range

Raw materials needed

Rubber, chemicals for condoms and lubricants, diagnostic reagents

Raw materials supplier

-

Recurring vs cyclical contribution

Majority revenue from recurring long-term export contracts; FMCG segment growing with potential for recurring sales.

Our industry position

Among top WHO/UNFPA prequalified suppliers globally, expanding FMCG presence.

Financial highlights

FY25 Revenue ₹183.5 Cr; Net Profit ₹40.9 Cr; Q3 FY26 revenue grew >100% YoY; net profit growth nearly 200%.

Geographical revenue split

Domestic sales 47%, International exports 53% (FY25 data)

Order book

Record-high multi-year order book provides strong revenue visibility.

Whats driving growth

Global public health demand, export contracts, FMCG expansion, capacity ramp-up, product diversification.

Our future plans

Expand manufacturing in India and Saudi Arabia, scale FMCG and diagnostics, leverage global certifications.

Our green promise

Installed solar energy systems, focus on environmental compliance and energy conservation.

Our people and values

Employee development programs, internal audits, and strong governance ensure robust culture and compliance.

Key challenges ahead

Sustaining export growth amidst competition, regulatory risks, and scaling new FMCG and diagnostics businesses.

Interesting facts

First Indian company with WHO-prequalified female condom; launched 15+ FMCG products in 2024-25.

Risks and strategy

Manages risks via certifications, internal controls, diversified product portfolio, and investment in scalable production.

Market Footprint

Top Clients

Top Clients

Global public health programs, governments, hospitals, retailers; operates B2B exports and B2C FMCG segments.

Top Products

Top Products

Male/Female condoms, lubricant jelly, in vitro diagnostic kits, deodorants, perfumes, face wash, and personal care items.

Price Movement & Share Holding

Today's High/Low

314.55326.75

52 Week High/Low

46368.95
Past Returns

1 week

-7.69%

1 month

18.92%

3 month

35.68%

1 year

541.68%

3 year

5116.42%

5 year

13818.14%

Share Holding

Promoters

47.69%

FII

4.69%

DII

1.2%

Retail

25.06%

Others

21.36%

Company Overview

Founded Year

1993

Listed Year

-

Headquarter

Nashik, Maharashtra, India

MD/CEO

Aditya Kumar Halwasiya (Chairman & Managing Director)

Website

https://www.cupidlimited.com

Price Movement & Share Holding

Today's High/Low

314.55326.75

52 Week High/Low

46368.95

Past Returns

1 week

-7.69%

1 month

18.92%

3 month

35.68%

1 year

541.68%

3 year

5116.42%

5 year

13818.14%

Share Holding

Promoters

47.69%

FII

4.69%

DII

1.2%

Retail

25.06%

Others

21.36%

Company Facts

What we do

Cupid Limited manufactures and exports male and female condoms, lubricant jelly, in vitro diagnostic devices, and personal care FMCG products with global certifications.

Founded in

1993

Market share

Leading global supplier with exports to 125+ countries, trusted by WHO/UNFPA and other global institutions.

Problem solved

Provides essential sexual health protection products and diagnostics addressing global public health and personal care needs.

Top clients or who we serve

Global public health programs, governments, hospitals, retailers; operates B2B exports and B2C FMCG segments.

Key management

Aditya Kumar Halwasiya (Chairman & Managing Director)

Our journey and innovations

Started in 1993 with male condoms; expanded to female condoms, lubricants, diagnostics (2023), and FMCG personal care products (2024).

Where we operate

Exports worldwide (125+ countries), domestic India market, expanding in GCC region.

Top products or what we offer

Male/Female condoms, lubricant jelly, in vitro diagnostic kits, deodorants, perfumes, face wash, and personal care items.

Top brands

Cupid condoms, Cupid Angel female condom, CupiSURE IVD kits, Cupid personal care range

Raw materials needed

Rubber, chemicals for condoms and lubricants, diagnostic reagents

Recurring vs cyclical contribution

Majority revenue from recurring long-term export contracts; FMCG segment growing with potential for recurring sales.

Our industry position

Among top WHO/UNFPA prequalified suppliers globally, expanding FMCG presence.

Financial highlights

FY25 Revenue ₹183.5 Cr; Net Profit ₹40.9 Cr; Q3 FY26 revenue grew >100% YoY; net profit growth nearly 200%.

Geographical revenue split

Domestic sales 47%, International exports 53% (FY25 data)

Order book

Record-high multi-year order book provides strong revenue visibility.

Whats driving growth

Global public health demand, export contracts, FMCG expansion, capacity ramp-up, product diversification.

Our future plans

Expand manufacturing in India and Saudi Arabia, scale FMCG and diagnostics, leverage global certifications.

Our green promise

Installed solar energy systems, focus on environmental compliance and energy conservation.

Our people and values

Employee development programs, internal audits, and strong governance ensure robust culture and compliance.

Key challenges ahead

Sustaining export growth amidst competition, regulatory risks, and scaling new FMCG and diagnostics businesses.

Interesting facts

First Indian company with WHO-prequalified female condom; launched 15+ FMCG products in 2024-25.

Risks and strategy

Manages risks via certifications, internal controls, diversified product portfolio, and investment in scalable production.

Market Footprint

Top Clients

Top Clients

Global public health programs, governments, hospitals, retailers; operates B2B exports and B2C FMCG segments.

Top Products

Top Products

Male/Female condoms, lubricant jelly, in vitro diagnostic kits, deodorants, perfumes, face wash, and personal care items.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions